您当前的位置：
首页 >
文章列表页 >
Optimization suggestions for the review and approval system of clinically urgent overseas-marketed drugs in China
更新时间：2026-06-26

    • Optimization suggestions for the review and approval system of clinically urgent overseas-marketed drugs in China

    • ZHONGGUO YAOFANG   Vol. 37, Issue 12, Pages: 1541-1546(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.12.04    

      CLC： R95

    • Received：05 February 2026，

      Revised：2026-02-27，

      Accepted：12 June 2026，

      Published：30 June 2026

    移动端阅览

  • SUN Tanlin,WANG Yuchen,XIAO Yue,et al.Optimization suggestions for the review and approval system of clinically urgent overseas-marketed drugs in China[J].ZHONGGUO YAOFANG,2026,37(12):1541-1546. DOI： 10.6039/j.issn.1001-0408.2026.12.04.

  •  
  •  

0

Views

10

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Effect evaluation of pharmaceutical service based on root cause analysis combined with KAP theory on decreasing the protocol violations of investigational medicinal products rate in pediatric clinical trials
Study on the mechanism of Euphorbia hirta L.-derived exosome-like nanovesicles regulating Nrf2/HO-1/NQO1 pathway to improve acetaminophen-induced liver injury
Protective effect of the active component DMDD from Averrhoa carambola root on myocardial injury in diabetic mice and its correlation with the NCOA4/FTH1/ATG8 axis
Study on the effect and mechanism of processed Oxytropis falcata in improving renal fibrosis in rats
Guidelines for standardized implementation of pharmacist-managed clinics （2026 edition）

Related Author

No data

Related Institution

No data
0